(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CSL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CSL

ST13

US500000087683942

Class

16, 40

Filing

87683942

Registration

5578603

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

07/29/2025

Trademark type

Word

Nice classes

16, 40

Filing date

11/14/2017

Registration date

10/09/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/07/2025

Last transaction

07/29/2025

Responsible office

United States Patent and Trademark Office

Status code

704

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

99

Owner location

Parkville, Victoria, AU

Examiner

KLEINMAN, CORINNE

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

CSL Limited
CSL Limited

Representatives

Scott D. Woldow Smith, Gambrell & Russell, LLP

Technical classification

Nice Classes

Class 16Class 40

Vienna Codes

No Vienna codes available.

Goods and services

Class 16

Printed matter and publicationsprinted instructional material and magazines featuring pharmaceutical productsvaccinesbloodblood productsbleeding disordersblood fractionationsrhesus prophylaxis and human autoimmune disorders; printed instructional and teaching materials in the field of pharmaceutical productsvaccinesbloodblood productsbleeding disordersblood fractionationsrhesus prophylaxis and human autoimmune disorders ; brochurespamphlets and informational flyers in the field of pharmaceutical productsvaccinesbloodblood productsbleeding disordersblood fractionationsrhesus prophylaxis and human autoimmune disorders ; posters and stationery relating to pharmaceutical productsvaccinesbloodblood productsbleeding disordersblood fractionationsrhesus prophylaxis and human autoimmune disorders

Class 40

Treatment of biological productscustom manufacturing and fractionation of blood

Publications

History of USPTO decisions and trademark events.

36 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

07/07/2025

8.PR

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED

07/07/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/07/2025

ES8R

TEAS SECTION 8 RECEIVED

03/28/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/09/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/11/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/11/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

10/11/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/11/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/11/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/11/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/17/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/17/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

10/09/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/24/2018

PUBO

PUBLISHED FOR OPPOSITION

07/24/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/04/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/21/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/31/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/31/2018

ALIE

ASSIGNED TO LIE

05/31/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/24/2018

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

05/24/2018

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

04/23/2018

GNSL

LETTER OF SUSPENSION E-MAILED

04/23/2018

CNSL

SUSPENSION LETTER WRITTEN

04/23/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

03/29/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/29/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

03/29/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/29/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/12/2018

GNRT

NON-FINAL ACTION E-MAILED

03/12/2018

CNRT

NON-FINAL ACTION WRITTEN

03/12/2018

DOCK

ASSIGNED TO EXAMINER

02/27/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/27/2017

NWAP

NEW APPLICATION ENTERED

11/17/2017

Continuous trademark protection

Get notified about every new filing that threatens CSL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.